Lv11
75 积分 2021-10-21 加入
Helicase-assisted continuous editing for programmable mutagenesis of endogenous genomes
1小时前
待确认
Ovarian cancer-derived IL-4 promotes immunotherapy resistance
6天前
已完结
The Hsp90 inhibitor IPI-504 rapidly lowers EML4–ALK levels and induces tumor regression in ALK-driven NSCLC models
26天前
已完结
Overcoming tyrosine kinase inhibitor resistance in lung cancer brain metastasis with CTLA4 blockade
1个月前
已完结
Intensive chemotherapy versus standard chemotherapy among patients with high risk, operable, triple negative breast cancer based on integrated mRNA-lncRNA signature (BCTOP-T-A01): randomised, multicentre, phase 3 trial
1个月前
已完结
Optimising first-line subtyping-based therapy in triple-negative breast cancer (FUTURE-SUPER): a multi-cohort, randomised, phase 2 trial
1个月前
已完结
Macrophage-mediated myelin recycling fuels brain cancer malignancy
3个月前
已完结
Protein tyrosine kinase inhibitor resistance in malignant tumors: molecular mechanisms and future perspective
3个月前
已关闭
ALK inhibitors: a new targeted therapy in the treatment of advanced NSCLC
5个月前
已完结
Concurrent inhibition of ALK and SRC kinases disrupts the ALK lung tumor cell proteome
6个月前
已完结
皖公网安备34019202002308
